Dalcetrapib: turning the tide for CETP inhibition?

Lancet. 2011 Oct 29;378(9802):1529-30. doi: 10.1016/S0140-6736(11)61421-9. Epub 2011 Sep 9.
No abstract available

Publication types

  • Comment

MeSH terms

  • Amides
  • Anticholesteremic Agents / administration & dosage*
  • Coronary Artery Disease / prevention & control*
  • Coronary Stenosis / prevention & control*
  • Diagnostic Imaging / methods*
  • Esters
  • Female
  • Humans
  • Hypercholesterolemia / drug therapy*
  • Male
  • Sulfhydryl Compounds / administration & dosage*

Substances

  • Amides
  • Anticholesteremic Agents
  • Esters
  • Sulfhydryl Compounds
  • dalcetrapib